2025 - Diabetes and Obesity-Related Drug Treatment Survey

1. Organization Name *This question is required.

2. Do you cover these medications on formulary? *This question is required.

Space Cell	Covered in 2025	Plan to Cover in 2026	Do not cover
GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro)	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Covered in 2025	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Plan to Cover in 2026	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Do not cover
GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound)	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Covered in 2025	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Plan to Cover in 2026	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Do not cover
Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli)	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Covered in 2025	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Plan to Cover in 2026	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Do not cover

3. What coverage tier are these medications covered in 2025? *This question is required.

Space Cell	Preventive	Preferred	Non-Preferred	Unknown	Other	Not Covered
GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro)	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Preventive	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Preferred	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Non-Preferred	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Unknown	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Other	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Not Covered
GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound)	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Preventive	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Preferred	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Non-Preferred	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Unknown	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Other	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Not Covered
Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli)	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Preventive	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Preferred	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Non-Preferred	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Unknown	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Other	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Not Covered

4. What coverage tier will these medications be covered in 2026? *This question is required.

Space Cell	Preventive	Preferred	Non-Preferred	Unknown	Other	Not Covered
GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro)	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Preventive	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Preferred	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Non-Preferred	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Unknown	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Other	GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro): Not Covered
GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound)	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Preventive	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Preferred	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Non-Preferred	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Unknown	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Other	GLP-1 Weight Loss Medications (e.g., Saxenda, Wegovy, Zepbound): Not Covered
Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli)	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Preventive	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Preferred	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Non-Preferred	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Unknown	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Other	Non GLP-1 Weight Loss Medications (e.g., Phentermine, Contrave, Adipex, Alli): Not Covered

5. Which Utilization Management do you have for GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro) in 2025? *This question is required.

Prior Authorization
Step Therapy
Quantity Limits
Program Participation
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.
Unknown (yes, some sort of Utilization Management)
No Utilization Management requirement
Medications Not Covered

6. Which Utilization Management do you plan to have for GLP-1 Diabetes Medications (e.g., Trulicity, Ozempic, Mounjaro) in 2026? *This question is required.

Prior Authorization
Step Therapy
Quantity Limits
Program Participation
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.
Unknown (yes, some sort of Utilization Management)
No Utilization Management requirement
Medications Not Covered

7. Which Utilization Management do you have for GLP-1 Weight Loss Medications (e.g. Saxenda, Wegovy, Zepbound) in 2025? *This question is required.

Prior Authorization
Step Therapy
Quantity Limits
Program Participation
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.
Unknown (yes, some sort of Utilization Management)
No Utilization Management requirements
Medications Not Covered

8. Which Utilization Management do you have for GLP-1 Weight Loss Medications (e.g. Saxenda, Wegovy, Zepbound) in 2026? *This question is required.

Prior Authorization
Step Therapy
Quantity Limits
Program Participation
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.
Unknown (yes, some sort of Utilization Management)
No Utilization Management requirements
Medications Not Covered

9. If you have a program targeted towards GLP-1 patients (either Diabetes or Obesity management), how is it integrated with your drug benefits? *This question is required.

No integration: program is contracted separately from PBM and completely optional for members/patients
Program is contracted separately from PBM, but has financial incentives for members/patients to participate (cost share, coverage tier, HSA contributions, etc.)
Program is contracted separately from PBM, but is required for GLP-1 coverage
Program is contracted through PBM, but completely optional for members/patients
Program is contracted through PBM and has financial incentives for members/patients to participate (cost share, coverage tier, HSA contributions, etc.)
Program is contracted through PBM and required for GLP-1 coverage (either Diabetes or Obesity products)
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.
No program targeted towards GLP-1 patients

10. Do you have transparency into GLP-1 rebates? If so, what are your approximate rebates for these medications? (as a % of allowed spend) *This question is required.

We don’t have transparency into rebate information
Approximately 0 – 25% of allowed spend is returned via rebates for these medications
Approximately 26 – 50% of allowed spend is returned via rebates for these medications
Approximately 51 – 74% of allowed spend is returned via rebates for these medications
Approximately 75 – 100% of allowed spend is returned via rebates for these medications
Other - Write In (Required) Please enter an 'other' value for this selection. * This question is required.